Vaccine Virtual Days 2024: Medical Education Event on Importance of Adult Immunisation - European Medical Journal

Vaccine Virtual Days 2024: Medical Education Event on Importance of Adult Immunisation

On 23-26 April 2024, join one of the world’s largest global medical education events dedicated to adult immunisation.

This educational event is organised and funded by GSK, and is intended for healthcare professionals only.


On 23-26 April, GSK will host the fifth edition of Vaccine Virtual Days, a free, four-day, virtual medical education event. This year’s event will be a contribution to the United Nations (UN) Decade of Healthy Ageing, bringing together health experts from around the world to discuss the challenges, opportunities and future of adult immunisation.

Registration is free of charge and recordings will be made available on demand after the live event.

CLICK HERE TO REGISTER

Discover the full agenda here and watch video to hear more from the event co-chairs:

  • Dr. Jane Barratt, PhD, Global Advisor at the International Federation on Ageing
  • Dr. Cedric “Jamie” Rutland, MD, Pulmonary and Critical Care Physician at Rutland Medical Group

The event programme was developed in cooperation with internationally-recognised experts and will span across three different time zones, covering the most pressing adult immunisation topics.

  • Day 1 – Immunology and Age-Related Decline in Immunity, Importance of Adult Immunisation and United Nations Decade of Healthy Ageing
  • Day 2 – Vaccine Preventable Respiratory Infectious Disease, Vaccination for Grown-Ups: Shared Clinical Decision Making Around Immunisation and Vaccine Equity
  • Day 3 – Patients at Increased Risk of Vaccine Preventable Disease and One Health
  • Day 4 – Patient Perspectives on the Path to Immunisation and Impact of Immunisation on Antimicrobial Resistance

Let science lead every day.

© 2024 GSK Group of Companies or its licensor. All rights reserved. GlaxoSmithKline Biologicals SA, Rixensart, Belgium.

NX-GBL-GVU-WCNT-240005 | March 2024

Rate this content's potential impact on patient outcomes

Thank you!

Please share some more information on the rating you have given